Jun 12, 2024   SOURCE: PR NewsWire

'Precision Medicine is Transforming Cancer Care' - Colorectal Cancer Resource & Action Network (CCRAN) Announces Second Annual Pan-Tumor Biomarkers Conference

TORONTO, June 12, 2024 /CNW/ - The Colorectal Cancer Resource & Action Network (CCRAN) is proud to announce their second annual Pan-Tumor Biomarkers Conference, scheduled to take place virtually on June 20-21, 2024, from 9:30 AM to 5:00 PM ET. This year's conference, focusing on the importance of equitable and timely access to advanced biomarker testing, is poised to be a landmark event in the field of oncology across 24 tumor types.

Advanced biomarker testing looks for mutations or alterations in a person's cancer (called biomarkers). These results help tailor treatment plans based on the cancer's specific characteristics, leading to personalized and often targeted precision medicines. Precision medicine is transforming cancer care, but timely and equitable access remain significant barriers. CCRAN is dedicated to overcoming these challenges and ensuring that metastatic cancer patients have access to advanced biomarker testing results.

    --  Pan-Tumor Patient Survey Results: A key feature of this year's
        conference is the presentation of findings from a pan-tumor biomarkers
        survey conducted in collaboration with 24 patient advocacy groups. This
        survey highlights patient experiences and perspectives, providing
        invaluable real-world evidence with respect to advanced biomarker
        testing, adding depth to the discussions and ensuring that the patient
        voices are at the forefront of our conference.
    --  Expert Panels: Hear from world-renowned experts, oncologists,
        researchers, pathologists, policymakers, advocacy groups, and patients
        as they discuss the latest advancements in biomarker testing and
        comprehensive genomic profiling (CGP).
    --  Clinician Discussions: Clinician roundtable discussions will shine a
        light on the importance of CGP and the role it can play in clinical
        practice, as well as the utility of ctDNA - a new diagnostic tool in the
        management of early and later stage cancers.

Join CCRAN and the 24 patient advocacy groups virtually on June 20-21(st) from 9:30 AM to 5:00 PM, as they pave the way towards a more equitable and effective cancer care landscape in Canada. Don't miss out on the chance to hear from experts across Canada and internationally! Register for FREE at https://bit.ly/BiomarkersConference.

CCRAN gratefully acknowledges the support of Merck, the Conference's Platinum Level sponsor, AstraZeneca and Roche, our Gold Level sponsors, and the balance of our supporting sponsors.

SOURCE Colorectal Cancer Resource & Action Network (CCRAN)